18-45837733-C-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_213602.3(SIGLEC15):c.333C>G(p.His111Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000643 in 1,506,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_213602.3 missense
Scores
Clinical Significance
Conservation
Publications
- Vici syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 152142Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000456 AC: 47AN: 103182 AF XY: 0.000429 show subpopulations
GnomAD4 exome AF: 0.000657 AC: 890AN: 1354136Hom.: 0 Cov.: 31 AF XY: 0.000619 AC XY: 414AN XY: 668346 show subpopulations
GnomAD4 genome AF: 0.000512 AC: 78AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000658 AC XY: 49AN XY: 74436 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.333C>G (p.H111Q) alteration is located in exon 3 (coding exon 3) of the SIGLEC15 gene. This alteration results from a C to G substitution at nucleotide position 333, causing the histidine (H) at amino acid position 111 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at